Mitawa Millin Missontsa, Françoise Bernaudin, Anne Fortin, Nathalie Dhédin, Corinne Pondarré, Karima Yakouben, Bénédicte Neven, Martin Castelle, Marina Cavazzana, Harry Lezeau, Matthieu Peycelon, Annabel Paye-Jaouen, Jeremy Sroussi, Tamara Diesch-Furlanetto, Virginie Barraud-Lange, Sabine Sarnacki, Mony Fahd, Isis Marchand, Clémence Delcour, Dominique Vexiau, Jean-Benoît Arlet, Annie Kamdem, Cécile Arnaud, Jean-Hugues Dalle, Catherine Poirot
PURPOSE: To describe the experience of performing ovarian tissue cryopreservation (OTC) before hematopoietic stem cell transplantation (HSCT), among girls/women with severe sickle cell disease (SCD)(SS or S/β0 -thalassemia) who are, besides the usual surgical risk, at risk of SCD-related complications during the fertility preservation procedure for improving their counseling and management. METHODS: This retrospective study included 75 patients (girls/women) with SCD who have had OTC before myeloablative conditioning regimen (MAC) for HSCT...
February 15, 2024: Journal of Assisted Reproduction and Genetics